Thrombophlebitis

Jump to navigation Jump to search

Template:Thrombophlebitis For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: White Leg; phlebitis

Overview

Historical Perspective

  • In 1913, Burnham AC discussed thrombophlebitis in postoperative patients.[1]
  • Historically, the treatment of thrombophlebitis was purely surgical and consisted of removal of the thrombosed vein.[2]

Classification

Thrombophlebitis can be classified according to the cause into:[3]

Type of Thrombophlebitis Description
Sterile Most common type of thrombophlebitis
Traumatic Associated with the following conditions:
Infective Mostly due to prolonged IV cannulation
Migratory Recurrent thrombophlebitis at various sites. Associated with an underlying malignancy, most commonly adenocarcinoma of the pancreas

Thrombophlebitis may also be classified according to the site into:[4]

  1. Superficial thrombophlebitis of the lower limb: most common location and it involves the great and short saphenous veins
  2. Superficial thrombophlebitis of the arms
  3. Superficial thrombophlebitis of the breast: also known as Mondor's disease
  4. Superficial thrombophlebitis of the abdominal wall

Pathophysiology

Pathogenesis

Microscopic Pathology

Genetics

Associated Conditions

Thrombophlebitis may be associated with the following conditions:

Causes

Common Causes

Causes by Organ System

Cardiovascular Deep veinous thrombosis, Levamisole-induced vasculopathy, Polyarteritis nodosa , Thromboangiitis obliterans, Thrombophlebitis migrans, Varicose veins, Vein injury
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Aprotinin, Caspofungin acetate, Cefepime, Cefoxitin sodium, Ceftazidime, Cidofovir, Clomifene, Desogestrel and ethinyl estradiol, Doripenem, Doxorubicin hydrochloride, Epirubicin, Ergonovine, Estramustine, Estropipate, Ethanolamine oleate, Ganciclovir, Hemin, Imipenem-cilastatin, Indomethacin, Letrozole, Levamisole-induced vasculopathy, Megestrol, Melarsoprol, Meropenem, Methocarbamol, Mitomycin, Naltrexone, Penicillamine, Penicillin g potassium, Pergolide, Piperacillin, Pramipexole, Prednisolone, Quinupristin-dalfopristin, Tiagabine, Toremifene, Tromethamine, Valganciclovir, Zonisamide
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic Inflammatory bowel disease, Pancreatic carcinoma, Parenteral nutrition
Genetic Genetics
Hematologic Blood transfusion , Intravenous infusion, Iv catheter infection, Penicillin g potassium, Prolonged sitting , Pulmonary embolism, Superficial thrombophlebitis, Thromboangiitis obliterans, Thrombophlebitis migrans
Iatrogenic Blood transfusion , Estrogen therapy, Intravenous infusion, Iv catheter infection
Infectious Disease Hiv
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic Parenteral nutrition
Obstetric/Gynecologic No underlying causes
Oncologic Pancreatic carcinoma
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary Pulmonary embolism
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy Behçet's disease, Lupus
Sexual Hiv
Trauma Prolonged sitting , Vein injury
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3

Differentiating Thrombophlebitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Screening

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:WikiDoc Sources

  1. Burnham AC (1913). "II. Postoperative Thrombophlebitis". Ann. Surg. 57 (2): 151–62. PMC 1407408. PMID 17862964.
  2. Homans J (1928). "THROMBOPHLEBITIS OF THE LOWER EXTREMITIES". Ann. Surg. 87 (5): 641–51. PMC 1398549. PMID 17865873.
  3. 3.0 3.1 Nasr H, Scriven JM (2015). "Superficial thrombophlebitis (superficial venous thrombosis)". BMJ. 350: h2039. PMID 26099257.
  4. Scott G, Mahdi AJ, Alikhan R (2015). "Superficial vein thrombosis: a current approach to management". Br. J. Haematol. 168 (5): 639–45. doi:10.1111/bjh.13255. PMID 25521017.
  5. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM (1999). "Genetic risk factors for superficial vein thrombosis". Thromb. Haemost. 82 (4): 1215–7. PMID 10544900.
  6. Olin JW (2000). "Thromboangiitis obliterans (Buerger's disease)". N. Engl. J. Med. 343 (12): 864–9. doi:10.1056/NEJM200009213431207. PMID 10995867.
  7. Diaconu C, Mateescu D, Bălăceanu A, Marcu M, Jianu V, Stănică A (2010). "Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report". J Med Life. 3 (1): 96–9. PMC 3019029. PMID 20302205.
  8. Varki A (2007). "Trousseau's syndrome: multiple definitions and multiple mechanisms". Blood. 110 (6): 1723–9. doi:10.1182/blood-2006-10-053736. PMC 1976377. PMID 17496204.